Travere Therapeutics names Bradley Campbell CEO effective Dec. 1
Travere Therapeutics appointed Bradley Campbell as president and chief executive officer, effective Dec. 1, as Eric Dube steps down to focus on health and family.
Travere Therapeutics named Bradley Campbell as president and chief executive officer, effective Dec. 1. Campbell's appointment comes as the biopharmaceutical company's president and CEO Eric Dube plans to step down to focus on his health and family, the company said Monday. Dube will…